CCEL Profile
Cryo-Cell International, Inc., headquartered in Oldsmar, Florida, is a prominent player in the field of cellular processing and cryogenic storage, specializing in the collection and preservation of umbilical cord blood stem cells for family use. Founded in 1989, Cryo-Cell has established itself as a leading provider in this niche market, offering cutting-edge solutions for stem cell preservation. The company’s core focus is on umbilical cord blood and cord tissue, leveraging advanced technology to support a variety of medical treatments and research.
The company's flagship service includes the collection and preservation of umbilical cord blood stem cells, which are pivotal in treating numerous medical conditions. These stem cells are critical for regenerative medicine, potentially addressing a range of diseases such as heart and kidney disorders, amyotrophic lateral sclerosis (ALS), wound healing, and autoimmune diseases. Additionally, Cryo-Cell offers cord tissue services, which involve the storage of umbilical cord tissueâ€an abundant source of mesenchymal stem cells with therapeutic potential in regenerative treatments.
Cryo-Cell International also manufactures and markets the PrepaCyte CB processing system, a sophisticated technology designed for the efficient processing of umbilical cord blood stem cells. This system is integral to the company's operations, ensuring high-quality preservation of stem cells. With a global repository of approximately 500,000 stored stem cell units, Cryo-Cell supports a vast network of families worldwide, providing them with peace of mind regarding their future healthcare needs.
To promote its services, Cryo-Cell International employs a multi-channel marketing strategy targeting expectant parents and healthcare professionals. The company distributes information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. This approach underscores Cryo-Cell’s commitment to education and outreach, ensuring that prospective clients are well-informed about the benefits of cord blood and tissue stem cell preservation.
|
